title: Chemotherapy-induced leukonychia.
authors.affiliation: Medicina Interna ed Oncologia Medica, Università di Pavia, IRCCS Policlinico S.Matteo, Pavia, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Benatti
authors.forename: Maurizia
authors.initials: M
authors.lastname: Gnocchi
authors.forename: Erica
authors.initials: E
authors.lastname: Travaglino
authors.forename: Rosangela
authors.initials: R
authors.lastname: Invernizzi
authors.forename: Edoardo
authors.initials: E
authors.lastname: Ascari
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001215:Asparaginase / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D009260:Nail Diseases / Q000139:chemically induced*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin